XML 27 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Convertible Preferred Shares and Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series C
Series D
Series D+
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Apr. 30, 2019 19,703,000              
Beginning balance at Apr. 30, 2019 $ 38,132              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of Series D/D+ convertible preferred shares, net of issuance costs (in shares)   2,448,000 10,094,000          
Issuance of Series D/D+ convertible preferred shares, net of issuance costs   $ 10,462 $ 50,023          
Ending balance (in shares) at Apr. 30, 2020 32,245,000              
Ending balance at Apr. 30, 2020 $ 98,617              
Beginning balance (in shares) at Apr. 30, 2019         70,694,000      
Beginning balance at Apr. 30, 2019 (12,817)       $ 4 $ 7,445 $ (170) $ (20,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Ordinary shares issued under employee share plan (in shares)         1,851,000      
Ordinary shares issued under employee share plan 814         814    
Share-based compensation 1,247         1,247    
Total comprehensive loss 1,348           19 1,329
Ending balance (in shares) at Apr. 30, 2020         72,545,000      
Ending balance at Apr. 30, 2020 $ (9,408)       $ 4 9,506 (151) (18,767)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of Series D/D+ convertible preferred shares, net of issuance costs (in shares)     9,934,000 8,630,000        
Issuance of Series D/D+ convertible preferred shares, net of issuance costs     $ 49,465 $ 49,883        
Ending balance (in shares) at Apr. 30, 2021 50,809,000              
Ending balance at Apr. 30, 2021 $ 197,965              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Ordinary shares issued under employee share plan (in shares)         2,613,000      
Ordinary shares issued under employee share plan 1,448         1,448    
Repurchase of ordinary shares (in shares)         (6,876,000)      
Repurchase of ordinary shares (22,908)       $ (1) (932)   (21,975)
Share-based compensation 2,570         2,570    
Total comprehensive loss $ (27,133)           378 (27,511)
Ending balance (in shares) at Apr. 30, 2021 68,282,000       68,282,000      
Ending balance at Apr. 30, 2021 $ (55,431)       $ 3 12,592 227 (68,253)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of Series D/D+ convertible preferred shares, net of issuance costs (in shares)       1,251,000        
Issuance of Series D/D+ convertible preferred shares, net of issuance costs       $ 7,245        
Conversion of preferred shares into ordinary shares (in shares) (52,060,000)              
Conversion of preferred shares into ordinary shares $ (205,210)              
Ending balance (in shares) at Apr. 30, 2022 0              
Ending balance at Apr. 30, 2022 $ 0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Ordinary shares issued under employee share plan (in shares)         3,029,000      
Ordinary shares issued under employee share plan 2,731         2,731    
Share-based compensation 9,188         9,188    
Total comprehensive loss (22,380)           (204) (22,176)
Conversion of preferred shares to ordinary shares (in shares)         52,060,000      
Conversion of preferred shares into ordinary shares 205,210       $ 3 205,207    
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares)         21,384,000      
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions 194,205       $ 1 194,204    
Warrant contra revenue $ 640         640    
Ending balance (in shares) at Apr. 30, 2022 144,755,000       144,755,000      
Ending balance at Apr. 30, 2022 $ 334,163       $ 7 $ 424,562 $ 23 $ (90,429)